申请人:Gravestock Barry Michael
公开号:US20060079695A1
公开(公告)日:2006-04-13
Compounds of the formula (I), or a pharmaceutically-acceptable salts, or in-vivo-hydrolysable esters thereo Formula (1): wherein N-HeT is for example triazolyl; Q is for example phenyl or pyridyl, substituted withr; T is for example selected from (TAa1 to TAa12) such as (TAa1) and (TAa5): R
4h
, R
5h
, R
6h
are for example selected from hydrogen, (1-4C)alkyl, (1-4C)alkoxy-carbonyl, (1-4C)alkanoyl and carbamoyl; processes for making them, compositions containing them and their use as antibacterial agents are described.
式(I)化合物,或其药学上可接受的盐,或其活体可水解的酯 式(1):其中 N-HeT 例如是三唑基;Q 例如是被r 取代的苯基或吡啶基;T 例如选自(TAa1 至 TAa12),如(TAa1)和(TAa5):R
4h
, R
5h
, R
6h
例如选自氢、(1-4C)烷基、(1-4C)烷氧基羰基、(1-4C)烷酰基和氨基甲酰基;描述了它们的制造工艺、含有它们的组合物以及它们作为抗菌剂的用途。